What caused 21P1.F stock to fall in pre-market trading?

21P1.F stock declined due to weak sector momentum, long inventory days (490.04) and ongoing negative EPS. Elevated volume suggests active selling; traders cite margin pressure and slow cash conversion as key drivers.

What is Meyka AI's 12-month forecast for 21P1.F stock?

Meyka AI's forecast model projects a 12‑month fair value of **€0.42** for 21P1.F stock, implying about **16.64%** upside from **€0.3601**. Forecasts are model-based and not guarantees.

Which support and resistance levels matter for 21P1.F stock?

Immediate support sits near **€0.35** and resistance near the 50‑day average at **€0.41**. A break above **€0.48** (200‑day average) would shift the trend, while a drop below **€0.25** increases downside risk.

How does Aurora Cannabis (21P1.F) compare to its sector?

Compared with Healthcare peers, 21P1.F shows stronger liquidity metrics but worse profitability. The sector average PE is near **28.79**, while Aurora’s negative EPS and long inventory cycle remain outliers.

DE Stocks

Pre-market: 21P1.F Aurora Cannabis (XETRA) €0.36 top loser: 12m fair value €0.42

ByHuzaifa Zahoor March 21, 2026March 21, 2026

21P1.F stock is trading in the XETRA pre-market at €0.36, down 2.86% from the previous close and showing elevated volume of 45,274 shares. Aurora Cannabis Inc. (21P1.F) ranks among today’s top losers on the Germany exchange as traders weigh weak sector momentum and stretched inventory metrics. We examine price action, fundamentals and a model-based 12‑month outlook to explain why the stock is under pressure and which levels matter for short-term traders and longer-term investors.